-
Research Services<a class="dhimg1" href="/shichangdetail1/9.html" target="_self" rel="nofollow"> <img src="https://omo-oss-image.thefastimg.com/portal-saas/pg2026042316544414203/cms/image/8926ff01-64bc-4928-a995-396bdb9d8102.jpg" alt="Aniphe BioLab"> </a> <a class="dhimg2" href="/shichangdetail/8.html" target="_self" rel="nofollow"> <img src="https://omo-oss-image.thefastimg.com/portal-saas/pg2026042316544414203/cms/image/26342b34-4f1e-4d28-9166-7b685e6d70c3.jpg" alt="Aniphe BioLab"> </a>
-
-
Preclinical CRO<a class="dhimg1" href="/shichangdetail/6.html" target="_self" rel="nofollow"> <img src="https://omo-oss-image.thefastimg.com/portal-saas/pg2026042316544414203/cms/image/cc43bac1-07d9-4340-9677-fbe01c51330a.jpg" alt="Aniphe BioLab"> </a> <a class="dhimg2" href="/shichangdetail/10.html" rel="nofollow" target="_self"> <img src="https://omo-oss-image.thefastimg.com/portal-saas/pg2026042316544414203/cms/image/f1d8f739-0d36-4cb8-adeb-26de791d909c.jpg" alt="Aniphe BioLab"> </a>
-
-
-
-
Oral disease models
Aniphe BioLab develops oral disease models based on key pathological mechanisms, including oral microenvironment dysregulation, bacterial infection, and inflammatory responses. These models support in vivo research on periodontitis, oral ulcers, pulpitis, and inflammatory diseases of the jawbone.
By reproducing local microbial dysbiosis, inflammatory cytokine release, and tissue damage, our models provide reliable platforms for disease mechanism studies and drug evaluation. Applications include anti-inflammatory and antimicrobial therapies, oral restorative materials, periodontal tissue regeneration, and local immune regulation.
Precision Modeling
System Verification
Repeatability
Accelerate R&D
Related Resources
Characteristics of Oral Disease Models from Aniphe BioLab
In response to the research needs surrounding dysregulation of the oral microenvironment and inflammatory injury,Aniphe BioLab has established a standardized animal model system for oral-related diseases, characterized by the following key features:
|
It encompasses common disease models such as periodontitis, oral ulcers, pulpitis, and mandibular osteomyelitis, meeting the needs of both basic research and pharmacological efficacy evaluation. |
Standardize the modeling method, stimulus intensity, and local treatment protocol to minimize the impact of procedural variability on experimental outcomes. |
By integrating histopathological analysis, inflammatory cytokine assays, and assessments of local structural changes, a comprehensive evaluation of inflammation and tissue damage can be achieved. |
Provide raw experimental data, pathological images, and analytical results to ensure data traceability and compliance with publication and regulatory submission requirements. |
Animal models of oral diseases, by mimicking local inflammation and tissue destruction, provide a stable and reproducible in vivo experimental platform for investigating the pathogenesis of oral disorders and for evaluating drugs and biomaterials.
Product List:
|
Disease Name |
Disease model |
Details |
|
|
U87-MG-luc orthotopic animal model |
View details → |
|
|
Alzheimer’s disease AD animal model |
View details → |
|
|
Animal model of allergic encephalomyelitis (AE) |
View details → |
|
|
Animal model of post-traumatic stress disorder (PTSD) |
View details → |
|
|
Animal model of traumatic brain injury |
View details → |
|
|
Epilepsy animal model |
View details → |
|
|
Animal model of spinal cord injury |
View details → |
|
|
Anxiety disorder animal model |
View details → |
|
|
Animal model of electrical stimulation for traumatic brain injury |
View details → |
|
|
Animal model of traumatic brain injury |
View details → |
|
|
Chronic Unpredictable Mild Stress (CUMS) animal model |
View details → |
|
|
Animal model of cerebral hemorrhage |
View details → |
|
|
Cerebral ischemia MCAO animal model |
View details → |
|
|
Sepsis-induced brain injury model |
View details → |
|
|
Parkinson’s disease animal model |
View details → |
|
|
Mild hepatic encephalopathy model |
View details → |
|
|
Hypoxic-ischemic encephalopathy (HIE) animal model |
View details → |
|
|
Trigeminal neuralgia animal model |
View details → |
|
|
Animal models of sleep disorders/insomnia |
View details → |
|
|
Vascular dementia animal model |
View details → |
|
|
Animal model of depression |
View details → |
|
|
Animal model of autoimmune encephalomyelitis |
View details → |
|
|
Sciatic nerve compression animal model |
View details → |
|
Disease Name |
Disease model |
Construction method |
|
|
Migraine model |
Nitroglycerin injection, dural inflammation-induced stimulation (application of inflammatory substances) |
|
|
Pituitaryectomy model |
Surgical removal of the pituitary gland (via the transsphenoidal or transcranial approach) |
|
|
Experimental model of osteomyelitis |
Tibial drilling and injection of Staphylococcus aureus |
|
|
Hypoxic preconditioning model |
Severe ischemia induced after repeated short-term hypoxic exposures (in normobaric or hypobaric chambers) |
|
|
Unilateral labyrinthectomy model |
Surgical destruction of the unilateral vestibular organ in rats and guinea pigs. |
|
|
Schizophrenia-induced osteoporosis model |
Long-term administration of antipsychotic agents (such as haloperidol) in combination with ovariectomy or glucocorticoid induction |
|
|
Cranial bone dissolution model |
Cranial implantation of titanium particles or inflammatory factors (TNF-α/polyethylene particles) |
|
|
Global cerebral ischemic epilepsy model |
Seizures following bilateral common carotid artery ligation combined with hypotension-induced ischemia |
Disease Name
Disease model
Details
|
Disease Name |
Disease model |
Construction method |
|
Recurrent oral ulcers |
Oral ulcer model |
Chemical cauterization, immunological methods |
|
Allergic rhinitis |
Allergic Rhinitis Model |
Intraperitoneal injection and intranasal administration of ovalbumin (OVA) |
|
Tympanic membrane perforation and hearing impairment |
Tympanic Membrane Perforation Model |
Surgical perforation method |
Aniphe BioLab Inc.
Address:
Runcheng, No. 8 Longtai Road, Jiangbei New Area, Nanjing City, Jiangsu Province
Building 8, Science Park
Postal Code: 210007
Phone:025-8520 8061
Email:info@aniphebio.com(Consultation)
Email:order@aniphebio.com(Order)
WeChat Official Account
Video Account















Su Public Security Bureau Internet Information Service Filing No. 32010402001421